The largest database of trusted experimental protocols
Sourced in United States, China, Germany

The SNU-387 is a laboratory equipment used for cell culturing. It is a specialized incubator that provides a controlled environment for the growth and maintenance of cell lines. The SNU-387 maintains precise temperature, humidity, and atmospheric conditions necessary for optimal cell culture conditions.

Automatically generated - may contain errors

85 protocols using snu 387

1

Culturing Human Liver Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HCC cell lines SNU387, SNU398, SNU449, and Hep3B were obtained from the ATCC (Manassas, VA, USA). SNU398 and SNU449 cells were cultured with Roswell Park Memorial Institute 1640 medium with 10% heat-inactivated fetal bovine serum, SNU387 cells were maintained in Roswell Park Memorial Institute 1640 medium with 10% fetal bovine serum, and Hep3B cells were cultured with ATCC-formulated Eagle's minimum essential medium with 10% fetal bovine serum. One hundred units of penicillin and streptomycin were added to each cell culture media.
+ Open protocol
+ Expand
2

Cell Culture Protocol for Hormone and Drug Treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse fibroblast NIH/3T3 (derived from male), human kidney cell HEK293T (derived from female), and human liver cancer cell line PLC/PRF/5 (derived from male) and SNU-387 (derived from female) were purchased from ATCC. Cell lines were authenticated by STR profiling. SNU-387 cells were cultured using ATCC-formulated RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS), 100 U/mL of penicillin, and 100 μg/mL of streptomycin at 37°C in 5% CO2. Other cell lines were cultured using DMEM high glucose medium (Thermo Fisher) supplemented with 10% FBS, 100 U/mL of penicillin, and 100 μg/mL of streptomycin. For hormone treatment experiments, cells were cultured and treated in phenol red-free DMEM (Thermo Fisher) supplemented with charcoal-stripped FBS (Biowest). Proteasome inhibition was induced by treatment of 10 μM of (R)-MG132 (Cayman Chemical) for 6 h. Selective HCN blocker ZD7288 was purchased from Tocris. Thapsigargin was purchased from Millipore-Sigma. Cells were treated with ZD7288 in a complete medium for 3 days.
+ Open protocol
+ Expand
3

Liver Biopsy for HCC Diagnosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Liver biopsy was performed for the diagnosis. During the biopsy, HCC tissues and paired non-tumor tissues (0.013–0.18 g) were collected. All tissue specimens were confirmed by histopathological examinations. Blood (5 ml) was collected from each patient in EDTA tubes at 0, 2, and 4 months of post-cisplatin-based therapies (65 mg/m2 on the 1st, 15th, and 29th days in a 1-month treatment course) and centrifuged at 1,200 g for 12 min to prepare plasma samples. Two HCC cell lines, SNU-475 and SNU-387 (ATCC, USA), were cultured in RPMI-1640 media (Cat# 11,875,093, Thermo Fisher, Shanghai, China) containing 100 IU/ml penicillin–streptomycin solution (Cat# 15140122, Thermo Fisher, Shanghai, China).
+ Open protocol
+ Expand
4

Maintenance of Hepatocellular Carcinoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human (HepG2, Hep3B, Huh7, SNU-387, and SNU-475; ATCC, Manassas VA), murine (Hepa1-6; ATCC), and Oncopig HCC cell lines were maintained in DMEM (or DMEM/F12 for HepG2) supplemented with 10% FBS and 1% Penicillin-Streptomycin.
+ Open protocol
+ Expand
5

Evaluating Doxycycline and ICG-001 in Liver Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Doxycycline hyclate (DOX, Sigma); ICG-001 (Selleckchem); fetal bovine serum, DMEM and DMEM/F12 medium (Gibco); fibroblast growth factor (FGF) and epidermal growth factor (EGF) (PeproTech); Trizol reagent (TAKARA); protease and phosphatase inhibitor cocktail (Roche); Lipofectamine 3000 and B27 (Invitrogen); dual-specific luciferase assay kit (Promega); Cell Counting Kit-8 (CCK8, Dojindo Molecular Technologies); Western blotting substrate (Millipore); Cell Signaling Senescence β-Galactosidase Staining Kit (CST); silver staining Rapid silver staining kit's (Beyotime); BALB/c nude mice (Beijing Vital River Laboratory Animal Technology); antibody against GATA4, Lamin B1, P21, FLAG, P15 and c-MYC (Abcam); HA and β-actin (Sigma); β-catenin, LEF1, TCF1, P14, P27, P53, p14/ARF, Caspase-9 and Caspase-3 (CST), P16/Ink4a (Epitomics); Cytokeratin (AE1/AE3) antibody (Kit-0009, MXB Biotechnologies) were purchased from the indicated manufacturers. SNU-387, SNU-449, PLC, NeHepLxHT, SK-Hep1, HepG2, HUH7 and HEK293 cells were obtained from ATCC.
+ Open protocol
+ Expand
6

Validated Hepatoma Cell Line Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
SNU387, SNU423, SNU475, Huh7, PLC/PRF/5 (HCC), HepG2 (Hepatoblastoma) and SKHep1 (adenocarcinoma of liver) were purchased from ATCC. Hep40 cells (HCC) were kindly provided by Prof. M. Ozturk (IBG, Izmir, Turkey). Cells were propagated in DMEM (PAA) supplemented with 10% FCS, Penicillin/Streptomycin (50 U/ml) and 2 mM L-Glutamine in a humidified, 5% CO2 incubator. The authenticity of Hepatoma cell lines were validated by STR analysis (Eurofins, Germany) and sequencing of p53 cDNA as they contain different p53 mutations12 (link). MycoAlert Mycoplasma Detection Kit (Lonza) has been used routinely to check mycoplasma contamination. Full-length human ZEB1 and ZEB2 cDNA were cloned into pCDNA4 plasmid with N-terminal HA-tag and sequence verified. E-Cadherin promoter luciferase reporter was used as described before11 (link). Transfections were performed using Lipofectamine LTX reagent (Invitrogen). Where necessary, cells were treated with TGFβ (R&D systems), UCN-01 and Midostaurin (Enzo Lifesciences), Oxaliplatin (Hospira, UK) and Sorafenib (Bayer, UK). All other chemicals were obtained from Sigma. Small hairpin RNA constructs (control and validated PKCα targeting, TRC no: TRCN0000195322-PKC-sh-1 and TRCN0000001693-PKC-sh-2) were purchased from Sigma.
+ Open protocol
+ Expand
7

Culturing Human Hepatocellular Carcinoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human HCC cell lines HEP3B and SNU387 were purchased from ATCC. Human HCC cell lines Huh7 and MHCC-97H were purchased from the National Collection of Authenticated Cell Cultures (https://www.cellbank.org.cn/). HEP3B cells were cultured in Minimum Essential Media (MEM, Gibco, 11095080) Supplementaryemented with 1% Non-Essential Amino Acids (NEAA, Sigma Aldrich, M7145) and 10% fetal bovine serum (FBS, Gibco, 12662029). Huh7, MHCC-97H, and SNU387 cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM, Gibco, 11995065) with 10% fetal bovine serum (FBS, Gibco, 12662029). All cells were cultured in a humidified incubator containing 5% CO2 at 37 °C.
+ Open protocol
+ Expand
8

Cytotoxicity Evaluation of Anti-Cancer Drugs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HCC cell lines SNU398, SNU387, Huh7, HepG2, and PLC/PRF/5 were obtained from ATCC. Cells were grown in Roswell Park Memorial Institute (RPMI) medium or Dulbecco’s Modified Eagle’s Medium (DMEM); supplemented with 10% fetal bovine serum (FBS), penicillin, and streptomycin; and maintained at 37°C with a 5% CO2 atmosphere. Regorafenib (#CS-1205) and sorafenib (#CS-0164) were purchased from ChemScene. Lenvatinib (#19375) and cabozantinib (#18464) were purchased from Cayman Chemical. Trametinib (#S-2673) was purchased from Selleck Chemicals, and buparlisib (#HY-70063) was from MedChem Express. Recombinant human IFNγ (#300-02) was obtained from PeproTech. Cell viability was quantified with Cell Count Reagent SF (nacalai tesque). Absorbance at 450 nm was measured on a micro- plate reader. For quantification of cytotoxicity, we used LDH Cytotoxicity Assay Kit (nacalai tesque). The absorbance value at 490 nm was measured.
+ Open protocol
+ Expand
9

Culturing Diverse Liver Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human hepatic normal cell line HL7702 and liver cancer cell lines QGY-7703 and SMMC7721 were purchased from Procell Life Science & Technology Co., Ltd. (Wuhan, China ), and cultured in high glucose DMEM (HyClone, Logan, USA) containing 10% FBS. The liver cancer cell line HepG2 was purchased from the National Collection of Authenticated Cell Cultures (Beijing, China) and cultured in RPMI 1640 (HyClone) supplemented with 10% FBS (HyClone). Human liver cancer cell lines, including SNU387, Huh7, and HCCLM3 cells, were obtained from ATCC (Manassas, USA) and cultured in high glucose DMEM (HyClone) containing 10% FBS. All cell lines were maintained at 37°C with 5% CO
2 in a humid atmosphere. Cell lines were tested for mycoplasma contamination using polymerase chain reaction.
+ Open protocol
+ Expand
10

Modulating Sorafenib Sensitivity in HCC

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human hepatocyte cell line THLE-2, and HCC cell lines Hep3B, SNU-182, SNU-387, SK-Hep1, and PLC/PRF/5 cells were purchased from ATCC (USA). The cells were cultured in RPMI 1640 medium containing 10% fetal bovine serum in an incubator at 37°C in 5% CO2. Cell culture-related reagents were purchased from Gibco (USA). To explore whether CDKN2B could regulate the sensitivity of HCC to Sorafenib, drug intervention was performed on Hep3B and SNU-182 cells. Sorafenib was purchased from Bayer Corporation (West Haven, CT, USA), and dimethylsulfoxide (DMSO) was purchased from KeyGen Biotech Co., Ltd. (Nanjing, China). Sorafenib was dissolved in DMSO and diluted with RPMI 1640 to the desired concentration for in vitro studies. In the control group, DMSO was added to cultures as a vehicle.
The wild-type CDKN2B coding sequence was subcloned into pcDNA3.1 (Sangon Biotech, China) to construct a pcDNA-CDKN2B expression vector. CDKN2B transfections were performed using Lipofectamine 2000 (Invitrogen, USA). siCDKN2B was purchased from GenePharma (China), and the siRNA transfections were performed by Lipofectamine 2000. The transfection efficiencies were detected using real-time quantitative polymerase chain reaction (RT-qPCR) and Western blot.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!